Stock fact sheet · data as of

Ultralife Corporation (ULBI): fair value, margin of safety and Wheel Score

Industrials · Electrical Equipment & Parts · United States · Speculative / Distressed

Close6.05
GLS fair value0.03141 of 9 models
Margin of safety-19170%price above fair value
Wheel Score21No optionscapped: no options
Health5/9Piotroski F-score
Moat2.8/10GLS 10-year score
Market cap$101M22k shares a day
Implied vol.-no listed options
P/E-EPS -0.39
Dividend yieldnone
Beta0.78moves less than the market
Next earnings22 Oct 2026in 6 days (before the open)

Is ULBI undervalued?

At 6.05 (close of 16 Oct 2026), ULBI trades 19170% over the GLS average fair value of 0.0314, with 0 of 1 models above the price. The stock earns none of the Wheel Score's Value points at this price. That is a statement about price against trailing fundamentals, not about the company's prospects - the Wall Street View and the Growth tab on the Quote page carry the forward numbers.

Only 1 of the nine models produced a value (10 Cap); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.

The nightly engine files ULBI under Speculative / Distressed - negative earnings or a Piotroski score of 3 or less - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for ULBI

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF--Present value of the projected free cash flows, discounted at the cost of capital; no value tonight
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap0.0314-99%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)1.14-81%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

Financial health is average - ULBI passes 5 of the nine Piotroski tests, which falls one point short of the Sunday Scan's "6 or more" rule. The Financials tab on the Quote page shows which tests fail. The GLS Moat score is low at 2.8 out of 10, which says the ten-year record of revenue, earnings, margins and returns on capital has been inconsistent - growth and shocks rather than steady compounding.

Returns on capital are thin or negative - ROIC -3.3%, ROE -4.5%, ROA -2.7% - with debt at 0.38 times equity and a free-cash-flow yield of 2.0%.

Ultralife Corporation pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Battery & Energy Products 80%, Communications Systems 20% (quarter Q4 FY2023).

Institutional ownership scores 4/10, insider activity 10/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score5 / 9ROIC-3.3%
GLS Moat2.8 / 10ROE-4.5%
Debt / equity0.38ROA-2.7%
Free-cash-flow yield2.0%Payout ratio0%
Institutions4 / 10Insiders · Congress10 · 5 / 10

Wheel Score 21: No options

ULBI has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (21 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at 22k shares a day on a market cap of $101M, with a beta of 0.78 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 6 of 20.

PartPointsFrom
Value0 / 25-19170% margin of safety
Health11 / 20Piotroski 5/9
Moat4 / 15moat 2.8/10
Premium0 / 20no option data
Stability6 / 2022k shares/day, $101M cap, beta 0.78

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

Ultralife Corporation reports earnings on 22 Oct 2026 (before the open) - inside the 14-day window the Sunday Scan avoids, because a put sold now would carry the report's gap risk.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Electrical Equipment & Parts

The 12 companies below are the closest to Ultralife Corporation by market cap within the Electrical Equipment & Parts industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
CBAT
CBAK Energy Technology, Inc.
1.1411.13+90%45Weak$101M
CEPL
Capstone Energy+, Inc.
3.263.30+1%22No options$106M
OESX
Orion Energy Systems, Inc.
23.26446.18+95%39No options$95M
RFIL
RF Industries, Ltd.
7.345.57-32%43Weak$80M
FAC
Factorial Energy Inc.
4.820.0532-8967%17Weak$133M
SKYX
SKYX Platforms Corp.
1.04--33No options$141M
NEOV
NeoVolta Inc
2.43--42Weak$143M
FCELB
FuelCell Energy, Inc.
465.00--22No options$145M
TGEN
Tecogen Inc.
2.30--32Weak$69M
ESP
Espey Mfg. & Electronics Corp.
56.3248.49-16%27No options$171M
LTBR
Lightbridge Corporation
5.358.21+35%45Weak$189M
MVST
Microvast Holdings, Inc.
0.56784.99+89%54Fair$189M

⚖ Compare ULBI with 7 of them   All Industrials stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about ULBI

Is ULBI undervalued right now?

No: at 6.05 the stock trades 19170% above the GLS average fair value of 0.0314 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.

What is the Wheel Score of ULBI and what does it mean?

ULBI has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".

What is the GLS fair value for ULBI?

0.0314 per share as of 16 Oct 2026 - the simple average of the 1 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Ultralife Corporation report earnings next?

The next earnings report is due on 22 Oct 2026 (before the open), 6 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.

Does ULBI have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on ULBI, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.